Increased Action Potential Duration & Cardiac Inotrophy View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

1988-1990

FUNDING AMOUNT

194860.0 USD

ABSTRACT

Several new compounds that concomitantly increase cardiac action potential duration and myocardial inotropy (e.g. OPC-8212, DPI 201-106, and d-sotalol) have been identified. Although the manner by which these compounds produce their cardiac effects is not well understood, the mechanism(s) responsible are clearly different from those responsible for the effects produced by cardiac glycosides. The purpose, therefore, of this project is to clarify the actions of these new compounds on cardiac ventricular muscle and specialized ventricular conducting tissue electromechanical activity and membrane currents; and, to access the relative importance of each of several possible mechanisms of action. The effects on cardiac action potential duration and developed force produced by these new compounds are similar to those produced by tetraethylammonium (TEA), which is known to reduce outward membrane potassium currents, and by veratridine and ATX II, which have been demonstrated to increase the time during which an inward, tetrodotoxin-sensitive, sodium current occurs during the action potential. These similarities suggest that the new compounds may also lengthen cardiac action potential duration by either reducing outward potassium currents or increasing the duration and magnitude of the inward sodium current. Lengthening action potential duration by either mechanism would be expected to increase intracellular sodium ion activity which, in turn, would be expected to increase intracellular free calcium and force development by affecting sodium-calcium exchange. In addition, it has been suggested that one of the new compounds (i.e. OPC-8212) is a phosphodiesterase inhibitor; and, that therefore, some of the electromechanical effects of this compound may be explained by phosphorylation of cardiac calcium channels and an increase in the magnitude of the inward calcium current. The studies will be performed on isolated rabbit Purkinje strands and rabbit ventricular trabeculae using ion-selective and conventional microelectrode techniques. Additional studies will be performed on enzymatically isolated rabbit Purkinje fiber and ventricular muscle myocytes using patch-clamp technqiues to record whole-cell and single-channel currents. The information to be obtained from these studies will help to clarify the ionic mechanisms responsible for the direct cardiac effects of each of the new compounds. The studies will also provide information that will help clarify the underlying differences in the ionic mechanisms responsible for genesis of the cardiac action potential in ventricular muscle and Purkinje fibers. Of greater importance, however, this study will provide useful information on novel and exciting mechanisms by which cardiac contractility may be pharmacologically increased while providing class III antiarrhythmic activity. More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=3352548

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "amount": {
      "currency": "USD", 
      "type": "MonetaryAmount", 
      "value": 194860.0
    }, 
    "description": "Several new compounds that concomitantly increase cardiac action potential duration and myocardial inotropy (e.g. OPC-8212, DPI 201-106, and d-sotalol) have been identified. Although the manner by which these compounds produce their cardiac effects is not well understood, the mechanism(s) responsible are clearly different from those responsible for the effects produced by cardiac glycosides. The purpose, therefore, of this project is to clarify the actions of these new compounds on cardiac ventricular muscle and specialized ventricular conducting tissue electromechanical activity and membrane currents; and, to access the relative importance of each of several possible mechanisms of action. The effects on cardiac action potential duration and developed force produced by these new compounds are similar to those produced by tetraethylammonium (TEA), which is known to reduce outward membrane potassium currents, and by veratridine and ATX II, which have been demonstrated to increase the time during which an inward, tetrodotoxin-sensitive, sodium current occurs during the action potential. These similarities suggest that the new compounds may also lengthen cardiac action potential duration by either reducing outward potassium currents or increasing the duration and magnitude of the inward sodium current. Lengthening action potential duration by either mechanism would be expected to increase intracellular sodium ion activity which, in turn, would be expected to increase intracellular free calcium and force development by affecting sodium-calcium exchange. In addition, it has been suggested that one of the new compounds (i.e. OPC-8212) is a phosphodiesterase inhibitor; and, that therefore, some of the electromechanical effects of this compound may be explained by phosphorylation of cardiac calcium channels and an increase in the magnitude of the inward calcium current. The studies will be performed on isolated rabbit Purkinje strands and rabbit ventricular trabeculae using ion-selective and conventional microelectrode techniques. Additional studies will be performed on enzymatically isolated rabbit Purkinje fiber and ventricular muscle myocytes using patch-clamp technqiues to record whole-cell and single-channel currents. The information to be obtained from these studies will help to clarify the ionic mechanisms responsible for the direct cardiac effects of each of the new compounds. The studies will also provide information that will help clarify the underlying differences in the ionic mechanisms responsible for genesis of the cardiac action potential in ventricular muscle and Purkinje fibers. Of greater importance, however, this study will provide useful information on novel and exciting mechanisms by which cardiac contractility may be pharmacologically increased while providing class III antiarrhythmic activity.", 
    "endDate": "1990-08-31", 
    "funder": {
      "id": "http://www.grid.ac/institutes/grid.279885.9", 
      "type": "Organization"
    }, 
    "id": "sg:grant.2532284", 
    "identifier": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "grant.2532284"
        ]
      }, 
      {
        "name": "nih_id", 
        "type": "PropertyValue", 
        "value": [
          "R01HL037034"
        ]
      }
    ], 
    "keywords": [
      "action potential duration", 
      "cardiac action potential duration", 
      "potential duration", 
      "cardiac effects", 
      "ventricular muscle", 
      "potassium current", 
      "action potentials", 
      "sodium current", 
      "Purkinje fibers", 
      "class III antiarrhythmic activity", 
      "direct cardiac effects", 
      "intracellular sodium ion activity", 
      "inward calcium current", 
      "rabbit Purkinje fibers", 
      "cardiac ventricular muscle", 
      "intracellular free calcium", 
      "outward potassium current", 
      "conventional microelectrode techniques", 
      "inward sodium current", 
      "cardiac calcium channels", 
      "sodium-calcium exchange", 
      "membrane potassium currents", 
      "cardiac action potential", 
      "ionic mechanisms", 
      "cardiac contractility", 
      "calcium current", 
      "antiarrhythmic activity", 
      "myocardial inotropy", 
      "ventricular trabeculae", 
      "calcium channels", 
      "ATX II", 
      "phosphodiesterase inhibitor", 
      "free calcium", 
      "cardiac glycosides", 
      "Additional studies", 
      "microelectrode techniques", 
      "membrane currents", 
      "force development", 
      "electromechanical activity", 
      "Purkinje strands", 
      "single-channel currents", 
      "sodium ion activity", 
      "duration", 
      "tetraethylammonium", 
      "muscle", 
      "possible mechanism", 
      "inotropy", 
      "new compounds", 
      "veratridine", 
      "contractility", 
      "study", 
      "activity", 
      "myocytes", 
      "effect", 
      "trabeculae", 
      "inhibitors", 
      "mechanism", 
      "action", 
      "calcium", 
      "phosphorylation", 
      "differences", 
      "useful information", 
      "glycosides", 
      "compounds", 
      "fibers", 
      "electromechanical effects", 
      "increase", 
      "potential", 
      "importance", 
      "information", 
      "manner", 
      "purpose", 
      "genesis", 
      "addition", 
      "development", 
      "ion activity", 
      "time", 
      "great importance", 
      "exciting mechanism", 
      "magnitude", 
      "relative importance", 
      "technique", 
      "turn", 
      "current", 
      "inwards", 
      "technqiues", 
      "similarity", 
      "channels", 
      "exchange", 
      "project", 
      "strands", 
      "force"
    ], 
    "name": "INCREASED ACTION POTENTIAL DURATION & CARDIAC INOTROPHY", 
    "recipient": [
      {
        "id": "http://www.grid.ac/institutes/grid.239573.9", 
        "type": "Organization"
      }, 
      {
        "affiliation": {
          "id": "http://www.grid.ac/institutes/None", 
          "name": "CINCINNATI CHILDRENS HOSP MED CTR", 
          "type": "Organization"
        }, 
        "familyName": "LATHROP", 
        "givenName": "DAVID A", 
        "id": "sg:person.0761162602.86", 
        "type": "Person"
      }, 
      {
        "member": "sg:person.0761162602.86", 
        "roleName": "PI", 
        "type": "Role"
      }
    ], 
    "sameAs": [
      "https://app.dimensions.ai/details/grant/grant.2532284"
    ], 
    "sdDataset": "grants", 
    "sdDatePublished": "2022-09-02T16:20", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/grant/grant_33.jsonl", 
    "startDate": "1988-07-01", 
    "type": "MonetaryGrant", 
    "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=3352548"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2532284'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2532284'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2532284'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2532284'


 

This table displays all metadata directly associated to this object as RDF triples.

136 TRIPLES      18 PREDICATES      113 URIs      105 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:grant.2532284 schema:about anzsrc-for:11
2 schema:amount Nc69754c2d59f478698d055edb8a1f402
3 schema:description Several new compounds that concomitantly increase cardiac action potential duration and myocardial inotropy (e.g. OPC-8212, DPI 201-106, and d-sotalol) have been identified. Although the manner by which these compounds produce their cardiac effects is not well understood, the mechanism(s) responsible are clearly different from those responsible for the effects produced by cardiac glycosides. The purpose, therefore, of this project is to clarify the actions of these new compounds on cardiac ventricular muscle and specialized ventricular conducting tissue electromechanical activity and membrane currents; and, to access the relative importance of each of several possible mechanisms of action. The effects on cardiac action potential duration and developed force produced by these new compounds are similar to those produced by tetraethylammonium (TEA), which is known to reduce outward membrane potassium currents, and by veratridine and ATX II, which have been demonstrated to increase the time during which an inward, tetrodotoxin-sensitive, sodium current occurs during the action potential. These similarities suggest that the new compounds may also lengthen cardiac action potential duration by either reducing outward potassium currents or increasing the duration and magnitude of the inward sodium current. Lengthening action potential duration by either mechanism would be expected to increase intracellular sodium ion activity which, in turn, would be expected to increase intracellular free calcium and force development by affecting sodium-calcium exchange. In addition, it has been suggested that one of the new compounds (i.e. OPC-8212) is a phosphodiesterase inhibitor; and, that therefore, some of the electromechanical effects of this compound may be explained by phosphorylation of cardiac calcium channels and an increase in the magnitude of the inward calcium current. The studies will be performed on isolated rabbit Purkinje strands and rabbit ventricular trabeculae using ion-selective and conventional microelectrode techniques. Additional studies will be performed on enzymatically isolated rabbit Purkinje fiber and ventricular muscle myocytes using patch-clamp technqiues to record whole-cell and single-channel currents. The information to be obtained from these studies will help to clarify the ionic mechanisms responsible for the direct cardiac effects of each of the new compounds. The studies will also provide information that will help clarify the underlying differences in the ionic mechanisms responsible for genesis of the cardiac action potential in ventricular muscle and Purkinje fibers. Of greater importance, however, this study will provide useful information on novel and exciting mechanisms by which cardiac contractility may be pharmacologically increased while providing class III antiarrhythmic activity.
4 schema:endDate 1990-08-31
5 schema:funder grid-institutes:grid.279885.9
6 schema:identifier N5d7e6d8e794d4aa2accbe416a44e3b91
7 N8e8ab267a3a4410fac70ba093d940fa1
8 schema:keywords ATX II
9 Additional studies
10 Purkinje fibers
11 Purkinje strands
12 action
13 action potential duration
14 action potentials
15 activity
16 addition
17 antiarrhythmic activity
18 calcium
19 calcium channels
20 calcium current
21 cardiac action potential
22 cardiac action potential duration
23 cardiac calcium channels
24 cardiac contractility
25 cardiac effects
26 cardiac glycosides
27 cardiac ventricular muscle
28 channels
29 class III antiarrhythmic activity
30 compounds
31 contractility
32 conventional microelectrode techniques
33 current
34 development
35 differences
36 direct cardiac effects
37 duration
38 effect
39 electromechanical activity
40 electromechanical effects
41 exchange
42 exciting mechanism
43 fibers
44 force
45 force development
46 free calcium
47 genesis
48 glycosides
49 great importance
50 importance
51 increase
52 information
53 inhibitors
54 inotropy
55 intracellular free calcium
56 intracellular sodium ion activity
57 inward calcium current
58 inward sodium current
59 inwards
60 ion activity
61 ionic mechanisms
62 magnitude
63 manner
64 mechanism
65 membrane currents
66 membrane potassium currents
67 microelectrode techniques
68 muscle
69 myocardial inotropy
70 myocytes
71 new compounds
72 outward potassium current
73 phosphodiesterase inhibitor
74 phosphorylation
75 possible mechanism
76 potassium current
77 potential
78 potential duration
79 project
80 purpose
81 rabbit Purkinje fibers
82 relative importance
83 similarity
84 single-channel currents
85 sodium current
86 sodium ion activity
87 sodium-calcium exchange
88 strands
89 study
90 technique
91 technqiues
92 tetraethylammonium
93 time
94 trabeculae
95 turn
96 useful information
97 ventricular muscle
98 ventricular trabeculae
99 veratridine
100 schema:name INCREASED ACTION POTENTIAL DURATION & CARDIAC INOTROPHY
101 schema:recipient Nd7231289b6d045609c8d1c9b7bf0885b
102 sg:person.0761162602.86
103 grid-institutes:grid.239573.9
104 schema:sameAs https://app.dimensions.ai/details/grant/grant.2532284
105 schema:sdDatePublished 2022-09-02T16:20
106 schema:sdLicense https://scigraph.springernature.com/explorer/license/
107 schema:sdPublisher N849ba735b207479ab17e585a7ea09a56
108 schema:startDate 1988-07-01
109 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=3352548
110 sgo:license sg:explorer/license/
111 sgo:sdDataset grants
112 rdf:type schema:MonetaryGrant
113 N5d7e6d8e794d4aa2accbe416a44e3b91 schema:name dimensions_id
114 schema:value grant.2532284
115 rdf:type schema:PropertyValue
116 N849ba735b207479ab17e585a7ea09a56 schema:name Springer Nature - SN SciGraph project
117 rdf:type schema:Organization
118 N8e8ab267a3a4410fac70ba093d940fa1 schema:name nih_id
119 schema:value R01HL037034
120 rdf:type schema:PropertyValue
121 Nc69754c2d59f478698d055edb8a1f402 schema:currency USD
122 schema:value 194860.0
123 rdf:type schema:MonetaryAmount
124 Nd7231289b6d045609c8d1c9b7bf0885b schema:member sg:person.0761162602.86
125 schema:roleName PI
126 rdf:type schema:Role
127 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
128 rdf:type schema:DefinedTerm
129 sg:person.0761162602.86 schema:affiliation grid-institutes:None
130 schema:familyName LATHROP
131 schema:givenName DAVID A
132 rdf:type schema:Person
133 grid-institutes:None schema:name CINCINNATI CHILDRENS HOSP MED CTR
134 rdf:type schema:Organization
135 grid-institutes:grid.239573.9 schema:Organization
136 grid-institutes:grid.279885.9 schema:Organization
 




Preview window. Press ESC to close (or click here)


...